Nitrogen-containing tricyclic compounds and uses thereof in medicine
US10562910B2 · kind B2 · utility
2Cited by
28References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2017 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Aug 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the use of the compound for the treatment of disease and/or condition mediated by FXR are described. And a pharmaceutical composition containing the compound disclosed herein and a method of treatment of disease and/or condition mediated by FXR comprising administering the compound or the pharmaceutical composition thereof are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.